Cure TV

Dr. Lori A. Leslie discuses the potential of combination therapies with the emerging agent cirmtuzumab for patients with mantle cell lymphoma.

Dr. Nathan A. Pennell discusses the key genetic markers for treating patients with non-small cell lung cancer with targeted therapies.

Many factors impact outcomes in patients with advanced renal cell carcinoma, but recent findings suggest a patient’s age and gender are perhaps more important than previously realized.

Despite recent advances in the treatment of multiple myeloma, more must be done to find effective treatment options for patients with advanced disease, according to Dr. Luciano J. Costa.

While the use of CAR-T cell therapy is currently still being investigated in patients with multiple myeloma, Dr. Nina Shah of the UCSF Helen Diller Family Comprehensive Cancer Center believes that these clinical trials will be what ultimately moves the field forward.

The future of multiple myeloma is heading toward combination therapies and CAR-T cell treatments, according to Dr. Betsy O'Donnell.

“Therapeutic trials are very, very important because thanks to them, our patients are living longer,” said Dr. Narjust Duma. “But (physicians) also need to stop and ask how our patients are living.”

Dr. Richard J. Gralla discusses some of the studies in supportive care that have been put on hold due to the ongoing COVID-19 pandemic.

Dr. Ricahrd J Gralla discusses the history of the early medical oncology space and how things have changed when it comes to treating side effects related to chemotherapy.

After a cancer diagnosis, Maryland Governor Larry Hogan had to lean on family from both his personal and professional life to helping take on treatment and beat cancer twice.

Genetic testing is proving itself to be a vital tool in treating patients with prostate cancer but educating men on its importance also needs to take priority.

“It really is an exciting time for patients with lymphoma, because the options are just really exploding at a very encouraging rate,” said Dr. Lori A. Leslie.

Dr. Toni K. Choueiri discusses what therapies are currently available for patients with metastatic renal cell carcinoma, as well as what new treatments could be on the horizon.

Dr. Parameswaran Hari discusses the importance of understanding a patient’s MRD if they are receiving the maintenance therapy Sarclisa for multiple myeloma.

Leading experts in the CLL landscape discuss the latest treatment options for patients and answer questions from the CURE audience.

There are some job protected options for patients with cancer, survivors and caregivers to consider when it comes to returning to work during the COVID-19 pandemic. But, as one cancer rights attorney notes, there are many challenges to those options.

The microorganisms inside a patient's gastrointestinal tract may have a role to play in how immunotherapy can treat certain types of cancer.

After being diagnosed with metastatic breast cancer, nurse Stephanie Walker was thrown into a world of isolation and new depths of depression she “never knew even existed”. Here, she details how working with a therapist and communicating with her family and friends helped her find her way out of the darkness.

“Laughter is the best medicine” is a principle that CURE Voices contributor Khevin Barnes takes, well, seriously. In this edition of CURE Community Vlogs, Khevin takes a minute to discuss how laughter can help men with breast cancer find a new outlook on their diagnosis.

While it may be tempting to “go to that dark place” when feeling the isolation that comes with metastatic breast cancer or a pandemic, Stephanie Walker shares her tips for how to emerge and connect with others.

In an interview with CURE®, Dr. Jorge Gomez discussed how recent developments in the assessment of biomarkers within the small cell lung cancer and non-small cell lung cancer space have led to approvals of new and expanded therapies.

CURE® interviews Voices contributor Tamera Anderson-Hanna on the benefits of continuing to perform yoga at home for both patients with cancer experiencing lymphedema, as well as caregivers looking to address their own mental well-being.

On the importance of finding more potent and well-tolerated therapies in hepatocellular carcinoma, Dr. Bruno Sangro explains: “The wider the spectrum of choices, the better we will be able to treat our patients.”

Dr. Timothy Burns, of UPMC Hillman Cancer Center, discusses developments in the treatment of lung cancer over the next several years that have exciting potential to impact the field.

Dr. Julia Rani Nangia explains how certain chemotherapy types and sequencing have different impacts on hair retention for patients with breast cancer.

Hair loss is a common side effect in treatment for cancer, but for patients looking to manage it Dr. Julie Rani Nangia breaks down how scalp cooling can slow down hair loss.

“When time passes, and you look back it seems like a distant memory.”

“One FDA approval that we were quite excited about (is Tabrecta). And I've actually already put some patients on it; it's a very good drug,” Dr. Timothy Burns said in a recent interview.